Tested Applications
| Positive IHC detected in | mouse colon tissue, human malignant melanoma tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
10453-1-AP targets SLC45A2 in WB, IHC, IF, ELISA applications and shows reactivity with human, mouse samples.
| Tested Reactivity | human, mouse |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag0699 Product name: Recombinant human SLC45A2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-159 aa of BC003597 Sequence: MGSNSGQAGRHIYKSLADDGPFDSVEPPKRPTSRLIMHSMAMFGREFCYAVEAAYVTPVLLSVGLPSSLYSIVWFLSPILGFLLQPVVGSASDHCRSRWGRRRPYILTLGVMMLVGMALYLNGATVVAALIANPRRKLVWAISVTMIGVVLFDFAADFI Predict reactive species |
| Full Name | solute carrier family 45, member 2 |
| Calculated Molecular Weight | 58 kDa |
| Observed Molecular Weight | 50-55 kDa |
| GenBank Accession Number | BC003597 |
| Gene Symbol | SLC45A2 |
| Gene ID (NCBI) | 51151 |
| RRID | AB_2191075 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q9UMX9 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
SLC45A2, also named as AIM1 and MATP, belongs to the glycoside-pentoside-hexuronide (GPH) cation symporter transporter (TC 2.A.2) family. It is a melanocyte differentiation antigen. SLC45A2 may transport substances required for melanin biosynthesis. (PMID:17768386,21677667)Mutation of SLC45A2 cause oculocutaneous albinism type 4 (OCA4) which is disorder of pigmentation characterized by reduced biosynthesis of melanin in the skin, hair and eyes.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for SLC45A2 antibody 10453-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The anti-SLC45A2 antibody (Cat# 10453-1-AP) has 3 total citations published in Journal of Investigative Dermatology, Frontiers in Immunology, and Frontiers in Oncology. The research spans genetics of oculocutaneous albinism and neutropenia, cholesterol metabolism dysregulation in metastatic uveal melanoma, and prognostic biomarker identification in skin cutaneous melanoma. Applications include WB, IF, and IHC in human samples.
| Species | Application | Title |
|---|---|---|
J Invest Dermatol Homozygosity mapping and whole-exome sequencing to detect SLC45A2 and G6PC3 mutations in a single patient with oculocutaneous albinism and neutropenia. | ||
Front Immunol Single-cell profiling deciphering cholesterol metabolism dysregulation in metastatic uveal melanoma and implicating SLC45A2 in its prognosis.
| ||
Front Oncol New Prognostic Biomarkers and Drug Targets for Skin Cutaneous Melanoma via Comprehensive Bioinformatic Analysis and Validation. |







